From Treating Illness to Predicting Risk: Vytalyou Raises ₹9 Crore to Scale Its Longevity Healthcare Vision

The Mumbai-based doctor-led startup is expanding beyond diagnostics with AI-powered health assessments, personalised preventive care and a growing network of longevity clinics.

Healthcare has traditionally followed a familiar pattern: something goes wrong, symptoms appear, a diagnosis is made, and treatment begins.

Vytalyou wants to move that timeline forward.

The Mumbai-based preventive healthcare and longevity startup has raised ₹9 crore in a Pre-Series A funding round from Chetan Jain of Pharma Dose and Ratan Jain of Venus Industries, at a valuation of approximately ₹33 crore. The fresh capital is set to accelerate the company’s expansion in Mumbai, where it plans to grow from its existing Powai centre to three locations, with new centres planned in Juhu and Worli.

Founded in 2025 by molecular oncologist Dr. Chirantan Bose and radiologist Dr. Preetesh Bhandari, Vytalyou is positioning itself at the intersection of diagnostics, preventive medicine and longevity-focused healthcare. Its stated objective is not simply to provide another health check-up, but to build a doctor-led system that combines health data, predictive assessments and personalised interventions.

₹9 Crore Funding Marks a New Phase of Expansion

The latest funding is significant for a company that was incorporated only in 2025.

An earlier September report from Business Standard described the investment as ₹8–10 crore in growth funding, secured in August 2026, and said the company was valued at around ₹33 crore. Subsequent reporting on September 30 confirmed the amount at ₹9 crore.

The immediate priority for the capital is geographic expansion.

Vytalyou currently operates its Powai centre and is setting up additional facilities in Juhu and Worli, creating a three-centre network in Mumbai. Beyond Mumbai, the company has outlined plans to expand to 10 locations across India in the coming years, with entry into other major Indian cities planned from 2027.

For Vytalyou, the funding therefore represents more than additional working capital. It is intended to turn an early-stage healthcare concept into a repeatable clinic network.

What Exactly Is Vytalyou Building?

Vytalyou describes its model as a doctor-led preventive longevity healthcare platform.

The company’s approach starts with diagnostics. Its current offering includes pathology and blood investigations, radiology, cardiovascular evaluation, body-composition analysis, genetic testing and other specialised assessments. The company also lists IV therapies, hyperbaric oxygen therapy, cryotherapy and other longevity-focused services among its offerings, with some services marked as coming soon.

At the centre of its proposition is what Vytalyou calls a Predictive Longevity Evaluation.

According to the company, its platform brings together information from areas such as biomarkers, body composition, genetics and lifestyle factors. The resulting assessment is intended to provide insights into biological age, health risks and areas that may require preventive attention. Doctors then review the information and develop personalised programmes.

This combination of technology and clinical supervision is an important part of the company’s positioning.

Rather than presenting AI as a substitute for physicians, Vytalyou says its assessments are reviewed by doctors before personalised care plans are developed.

A Healthcare Model Built Around Prevention

The founders’ philosophy is centred on shifting healthcare from a predominantly reactive model towards prevention.

In a recent statement following the funding announcement, Dr. Chirantan Bose described the company’s mission as adding healthy years to life and addressing major sources of morbidity, including cardiovascular disease, diabetes, cancer, respiratory conditions and neurological disease.

The company’s website similarly describes its approach as beginning with a comprehensive health assessment, followed by an AI-guided longevity analysis, personalised interventions and ongoing monitoring.

This is where Vytalyou is attempting to distinguish itself from a conventional diagnostic centre.

Diagnostics are positioned as the starting point rather than the final product. The company’s model is designed to connect the information generated by tests with physician-led interpretation and personalised wellness or preventive programmes.

Early Customer Traction

Despite being a relatively young company, Vytalyou says it has already served nearly 1,000 clients since opening its first centre in Powai.

According to recent reports, approximately half of these customers came through walk-ins, while the other half came through word-of-mouth referrals.

That early traction is particularly relevant to a clinic-based startup because physical healthcare businesses need to establish both customer trust and repeat demand before expanding their footprint.

The referral component also gives an indication of how Vytalyou says its initial customer base has developed, although the company is still at an early stage and its larger expansion plans remain ahead.

The Founders Bring Clinical Expertise to the Startup

Vytalyou’s founding team is built around two medical specialists.

Dr. Chirantan Bose, a molecular oncologist, brings expertise in areas including molecular diagnostics and genomics. Dr. Preetesh Bhandari, a radiologist, brings experience in diagnostic imaging. The company says this clinical background is central to its approach to preventive healthcare.

The founders have also spoken about their intention to use technology and their clinical experience to identify potential health risks before they become more difficult to manage.

Dr. Bose recently said the company had worked with alumni from IIT Bombay on its predictive longevity algorithm, which the company says is designed to assess biological and functional age and inform personalised programmes. These are company-reported capabilities and goals rather than independently validated evidence that the system can extend lifespan.

Why the Vytalyou Story Is Worth Watching

The funding comes as the broader Indian healthcare startup ecosystem continues to see activity around preventive care, diagnostics, longevity and personalised health.

Vytalyou is entering that space with a model that combines several components that have traditionally operated separately: diagnostic testing, physician consultation, data analysis, wellness interventions and ongoing monitoring.

Its challenge now is scale.

Building three centres in Mumbai is one step; creating a consistent medical and customer experience across 10 locations is a considerably larger operational task. As the company expands, maintaining physician oversight, clinical standards, data quality and patient trust will be critical to the model.

The distinction between evidence-based preventive healthcare and the broader commercial longevity market will also remain important as the sector develops. Some of the interventions promoted within the longevity industry have varying levels of scientific evidence, making clinical governance and transparent communication particularly relevant for companies operating in this category.

What Comes Next for Vytalyou?

For now, Vytalyou’s roadmap is focused on execution.

The ₹9 crore funding will support the company’s expansion from Powai into Juhu and Worli, taking its Mumbai footprint to three centres. The longer-term plan is to reach 10 locations across India, with expansion into other major cities expected to begin in 2027.

The company is also building out its broader platform around diagnostics, AI-assisted health analysis and personalised interventions.

Whether Vytalyou ultimately becomes a large-scale healthcare network will depend on how effectively it can translate its doctor-led model from one centre into multiple locations while maintaining quality and trust.

But its latest funding round signals a clear shift from experimentation to expansion.

Vytalyou is betting that the future of healthcare will not begin when people become patients. It will begin much earlier — with understanding risk, measuring health and acting before disease forces the conversation.

For a startup founded just a year ago, the next chapter will be about proving whether that philosophy can become a scalable healthcare business in India.

Written By
Divya